Based on the characteristics of neuroendocrine tumors using MTC, detecting serum biomarker Ctn levels (individually or in combination with CEA testing) has been used for preoperative diagnosis (24). This evidence concerns the gene CEACAM5 and neuroendocrine neoplasm.